Dario Parini

Dr. Dario Parini

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
ACand Federico Coccolini
and Federico Coccolini
Francesco CorradiFrancesco Corradi
Francesco Corradi
MSMassimo Sartelli
Massimo Sartelli
RCRaul Coimbra
Raul Coimbra
IKIgor A. Kryvoruchko
Igor A. Kryvoruchko
Manu MalbrainManu Malbrain
Manu Malbrain
Background: Non-traumatic emergency general surgery involves a heterogeneous population that may present with several underlying diseases. Timeous emergency surgical treatment should be supplemented with high-quality perioperative care, ideally performed by multidisciplinary teams trained to identify and handle complex postoperative courses. Uncontrolled or poorly controlled acute postoperative pain may result in significant complications. While pain management after elective surgery has been standardized in perioperative pathways, the traditional perioperative treatment of patients undergoing emergency surgery is often a haphazard practice. The present recommended pain management guidelines are for pain management after non-traumatic emergency surgical intervention. It is meant to provide clinicians a list of indications to prescribe the optimal analgesics even in the absence of a multidisciplinary pain team. Material and methods: An international expert panel discussed the different issues in subsequent rounds. Four international recognized scientific societies: World Society of Emergency Surgery (WSES), Global Alliance for Infection in Surgery (GAIS), Italian Society of Anesthesia, Analgesia Intensive Care (SIAARTI), and American Association for the Surgery of Trauma (AAST), endorsed the project and approved the final manuscript. Conclusion: Dealing with acute postoperative pain in the emergency abdominal surgery setting is complex, requires special attention, and should be multidisciplinary. Several tools are available, and their combination is mandatory whenever is possible. Analgesic approach to the various situations and conditions should be patient based and tailored according to procedure, pathology, age, response, and available expertise. A better understanding of the patho-mechanisms of postoperative pain for short- and long-term outcomes is necessary to improve prophylactic and treatment strategies.

21 September 2023 in International Journal of Surgery
Verified
Journal Article
Open access
FFFrancesca De Felice
Francesca De Felice
CCCarlo Guglielmo Cattaneo
Carlo Guglielmo Cattaneo
GPGianmario Edoardo Poto
Gianmario Edoardo Poto
CACarmine Antropoli
Carmine Antropoli
ABAntonio Brillantino
Antonio Brillantino
Luigi MaranoLuigi Marano
Luigi Marano
The ongoing global health challenge of cancer is driving the pursuit of innovative avenues for prevention, treatment, and enhanced outcomes. The convergence of nutrition and immune modulation, known as immunonutrition, is ready to act as a catalyst for transformative change in cancer research and therapy. Our study employs a bibliometric analysis to uncover the evolving trends within immunonutrition and cancer research across the past 25 years. Bibliometric data, including authors, journals, affiliations, and countries, were analyzed using the Bibliometrix R package. Clustering algorithms were applied to keywords to identify thematic areas and their evolution. A total of 489 documents were analyzed, showing an annual growth rate of 8.7%, with a collaboration index of 5.41, highlighting comprehensive multidisciplinary involvement within this landscape. Core authors demonstrated sustained productivity, while occasional authors indicated widespread interest. The Medical University of Warsaw led in institutional contributions. Country-wise, Italy, France, and the USA emerged as forerunners in fostering research productivity. Key journals like ʻClinical Nutritionʼ served as beacons, emphasizing the multidimensional nature of this topic. The analysis highlighted growing research output and several collaborations, indicating the importance of immunoenriched nutrition in cancer treatment. The interplay of core authors and diversified engagement harmoniously accentuates the cross-disciplinary nature of this burgeoning field. International collaboration facilitated knowledge exchange. Prominent documents shaped the field, emphasizing the significance of nutritional interventions. Thematic clusters revealed varied focuses, including pharmaconutrients, surgical approaches, inflammation, and specific cancers. The expanding research output suggests further development, particularly in exploring immunoenriched nutrition’s impact on cancer types and patient populations. The multidisciplinary nature and international collaborations enhance the field’s progress. Gaps in research underscore the need for original studies and personalized approaches. This study guides future research, informing evidence-based nutritional interventions and advancing cancer care practices.

9 February 2026 in Cancers
Verified
Journal Article
Open access
PDF file
OSOttavia De Simoni
Ottavia De Simoni
MSMelania Scarpa
Melania Scarpa
FCFrancesco Cavallin
Francesco Cavallin
AKAndromachi Kotsafti
Andromachi Kotsafti
FMFrancesco Marchegiani
Francesco Marchegiani
MSMarco Scarpa
Marco Scarpa
Background: Anastomotic leaks (ALs) remain a critical complication after rectal cancer surgery. Emerging evidence suggests that local immune dysregulation may play a key role in anastomotic healing. We investigated the immune microenvironment of histologically normal, tumor-adjacent rectal mucosa—a tumor-conditioned field—as a potential substrate for AL predisposition. Methods: IMMUNOREACT 4 is a sub-analysis of the IMMUNOREACT project (clinicaltrials.gov NCT04915326 and NCT04915326), a multicenter translational study evaluating immune features of histologically normal, tumor-adjacent rectal mucosa of patients undergoing colorectal anastomosis. A prospective cohort (n = 121) was analyzed using flow cytometry, in addition to a retrospective cohort (n = 262) using immunohistochemistry. Immune markers of epithelial activation and lymphocyte subsets were compared between patients with and without postoperative ALs. Exploratory predictive models combining immune and clinical variables were developed and evaluated using discrimination, calibration and decision curve analyses. Results: At flow cytometry, the CK+HLAabc+ MFI (AUC 0.66, 95% CI 0.52–0.80), CD8+CD38+ cell rate (AUC 0.65, 95% CI 0.52–0.78) and CD3+CTLA4+ cell rate (AUC 0.65, 95% CI 0.51–0.80) showed moderate predictive potential for ALs. In immunohistochemistry, CD3+ (AUC 0.57, 95% CI 0.54–0.60), CD8+ (AUC 0.57, 95% CI 0.52–0.62), CD8β+ (AUC 0.59, 95% CI 0.53–0.65) and Tbet+ (AUC 0.60, 95% CI 0.56–0.64) showed some predictive ability for ALs. The model including CD8β+, the BMI, neutrophile/lymphocyte ratio and tumor location had an AUC of 0.67 (95% CI 0.62–0.72). Conclusions: Immune activation within histologically normal, tumor-adjacent rectal mucosa—characterized by epithelial HLA upregulation and cytotoxic or Th1 T cell infiltration—is associated with postoperative ALs. Although predictive accuracy is limited, these findings support the concept that a tumor-conditioned immune microenvironment may predispose patients to impaired anastomotic healing. Integration of mucosal immune profiling with clinical variables represents a promising exploratory approach that warrants further prospective validation.

16 December 2023 in Updates in Surgery
Verified
Journal Article
Closed access
PDF file
DVDiego Visconti
Diego Visconti
DPDario Parini
Dario Parini
DMDiego Mariani
Diego Mariani
ABAlan Biloslavo
Alan Biloslavo
GBGabriele Bellio
Gabriele Bellio
MCMassimo Chiarugi
Massimo Chiarugi

15 June 2026 in Cancers
Verified
Journal Article
Open access
PDF file
LDLorenzo Dell'Atti
Lorenzo Dell'Atti
AKAndromachi Kotsafti
Andromachi Kotsafti
FGFrancesca Galuppini
Francesca Galuppini
MSMelania Scarpa
Melania Scarpa
RSROBERTA SALMASO
ROBERTA SALMASO
MSMarco Scarpa
Marco Scarpa
Background/Objectives: Mucinous adenocarcinoma (MAC) is a rare and clinically problematic subtype of rectal cancer, tending to present at an advanced stage and to respond poorly to neoadjuvant therapy. The consistently worse prognosis than that of not-otherwise-specified adenocarcinoma (NOS-AC) is not fully understood, potentially owing to intrinsically more aggressive biology or specific immune evasion mechanisms. We used the IMMUNOREACT multicentre cohort, with external validation in TCGA, to investigate the clinical and immunological features of rectal MAC in detail. Methods: Two hundred patients with rectal adenocarcinoma (16 MAC, 184 NOS-AC) from the IMMUNOREACT 1 (NCT04915326) and IMMUNOREACT 2 (NCT04917263) prospective cohorts were included. To account for the imbalance in baseline characteristics, propensity score matching (PSM) was performed on age, sex, neoadjuvant treatment and TNM stage. The immune microenvironment was characterised using immunohistochemistry (CD3, CD4, CD8, CD8β, Tbet, FoxP3, PD-L1, MSH6, PMS2, CD80), flow cytometry and NanoString PanCancer IO 360™ transcriptomics of adjacent healthy mucosa. Findings were externally validated against TCGA rectal and colon adenocarcinoma datasets. Results: MAC presented at significantly more advanced stage than NOS-AC across all TNM parameters: higher T stage (p = 0.006), N stage (p < 0.001), M stage (p = 0.039) and overall TNM stage (p < 0.001). In the unmatched cohort, MAC was associated with worse overall survival (HR 2.53; 95% CI 1.03–6.23; p = 0.043) and disease-free survival (HR 2.86; 95% CI 1.25–6.55; p = 0.013), but both differences became non-significant after PSM. MAC patients had higher haemoglobin after adjusting for confounders (mean difference [MD] 1.26 g/dL, 95% CI 0.30–2.31, p = 0.012), consistent with a hypothesis of reduced chronic rectal bleeding as a possible mechanism for late presentation. Transcriptomically, MAC showed suppression of HLA class II antigen presentation genes (HLA-DQA1, HLA-DQB1, HLA-DRB1) and myeloid activation genes (S100A8/A9/A12) in adjacent healthy mucosa. Loss of MMR proteins MSH6 and PMS2 in histologically normal mucosa was significantly more frequent in MAC. These findings were replicated in the TCGA cohort, which also showed lower tumour mutational burden and a distinct mucin-associated transcriptomic profile in MAC. Conclusions: The worse outcomes of rectal MAC appear to be driven largely by late-stage presentation, possibly owing to later diagnosis. MAC nonetheless carries a distinct immune phenotype, detectable even in histologically normal surrounding mucosa, that likely contributes to its treatment resistance. These observations provide a basis for developing histotype-specific approaches to both early detection and treatment in this uncommon but clinically challenging tumour subtype.

21 May 2026 in Medicina
Verified
Journal Article
Open access
PDF file
LDLorenzo Dell'Atti
Lorenzo Dell'Atti
MZMaurizio Zizzo
Maurizio Zizzo
AMAndrea Morini
Andrea Morini
FMFederica Mereu
Federica Mereu
MSMarco Scarpa
Marco Scarpa
MPMassimiliano Fabozzi, MD, PhD
Massimiliano Fabozzi, MD, PhD
Background and Objectives: Perforated peptic ulcer (PPU) is an emergent condition managed by surgical intervention. No conclusive evidence has been produced regarding the need for drain placement after primary repair. Our meta-analysis aimed to provide insight into the short-term outcomes by comparing the two strategies of drain omission or intra-operative placement of at least one drain. Materials and Methods: We performed a systematic review following the PRISMA guidelines. PubMed/MEDLINE, Web of Science, Cochrane Library, and Embase databases were utilized to identify articles of interest. Meta-analysis was performed using RevMan Version 5.4. Eligible studies were comparative studies (RCTs and observational studies) enrolling adult patients (≥18 years) undergoing emergency primary repair for PPU, with or without prophylactic intra-abdominal drain placement; case reports and series of fewer than 10 patients were excluded. The literature search covered January 2010 to 22 February 2026. Risk of bias was assessed using the Cochrane RoB 2.0 tool for RCTs, and the ROBINS-I V2 tool for observational studies; certainty of evidence was graded using the GRADE framework. Pooled effect estimates were calculated using a random-effects model and expressed as odds ratios (OR) or mean differences (MD) with 95% confidence intervals (CI); statistical heterogeneity was quantified using the I2 statistic. Results: Five studies were considered for comparison, for a total of 1354 patients (744 and 610 in the drain and no-drain groups, respectively). Three were randomized controlled trials, and two were retrospective cohort studies, conducted across four countries (India, the USA, Egypt, and Japan). Meta-analysis of the pooled results showed that drain omission was associated with a shorter length of stay (LOS) (MD −2.13, 95% CI [−3.91–−0.35], p < 0.0001) and a lower rate of superficial surgical site infections (SSIs) (16.7% vs. 52.7%, OR 0.24, 95%CI [0.11–0.55], p = 0.0007). No difference was observed regarding the rate of leaks, reoperation, or deep SSIs. Low-certainty evidence suggested higher postoperative mortality in the no-drain group (OR: 1.96; 95% CI: 1.10 to 3.48; p = 0.02; I2 = 0%), largely driven by retrospective studies with a high risk of bias. This mortality finding is of very low certainty and is most likely attributable to confounding in the observational studies rather than a true causal effect of drain omission. Several outcomes were based on data from only two to three studies, and the overall certainty of evidence was low to very low. Conclusions: Drain omission after primary repair for PPU may be associated with better outcomes in terms of LOS and superficial SSIs, primarily in lower-acuity patients, as reflected by the inclusion criteria of the contributing RCTs. Pooled analysis showed a higher postoperative mortality in the no-drain group; however, given the significant biases among included studies, our results should be interpreted as non-causal and thus require careful interpretation. Further research encompassing the full clinical spectrum of PPU is needed to confirm our results. Evidence certainty was low to very low across all outcomes, primarily due to a risk of bias, high heterogeneity (I2 up to 95% for LOS), indirectness, and imprecision.